Current Assets
Prepaid & Other Current
Neurocrine Biosciences Prepaid & Other Current increased by 30.3% to $27.50M in Q1 2026 compared to the prior quarter. Year-over-year, this metric declined by 76.9%, from $119.30M to $27.50M. Over 5 years (FY 2020 to FY 2025), Prepaid & Other Current shows a downward trend with a -6.9% CAGR.
Analysis
StatementBalance Sheet Statement
SectionCurrent Assets
CategoryLiquidity
SignalContext dependent
VolatilityStable
First reportedQ4 2014
Last reportedQ1 2026May 5, 2026
How to read this metric
Significant fluctuations may indicate changes in corporate procurement cycles or shifts in accounting for short-term financial instruments.
Detailed definition
Payments made in advance for services or goods to be received within the next year, alongside other miscellaneous short-...
Peer comparison
Generally a small percentage of current assets; large spikes may warrant investigation into non-recurring items.
Metric ID:
prepaid_and_other_current_assetsHistorical Data
20 periods
| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $38.40M | $50.50M | $45.50M | $60.80M | $62.70M | $67.90M | $79.10M | $113.20M | $100.60M | $108.20M | $97.80M | $100.50M | $120.20M | $121.70M | $48.50M | $119.30M | $120.70M | $178.10M | $21.10M | $27.50M |
| QoQ Change | — | +31.5% | -9.9% | +33.6% | +3.1% | +8.3% | +16.5% | +43.1% | -11.1% | +7.6% | -9.6% | +2.8% | +19.6% | +1.2% | -60.1% | +146.0% | +1.2% | +47.6% | -88.2% | +30.3% |
| YoY Change | — | — | — | — | +63.3% | +34.5% | +73.8% | +86.2% | +60.4% | +59.4% | +23.6% | -11.2% | +19.5% | +12.5% | -50.4% | +18.7% | +0.4% | +46.3% | -56.5% | -76.9% |
Range$21.10M – $178.10M
CAGR-6.8%
Avg YoY Growth+19.0%
Median YoY Growth+21.6%
Prepaid & Other Current at Other Companies
Frequently Asked Questions
- What is Neurocrine Biosciences's prepaid & other current?
- Neurocrine Biosciences (NBIX) reported prepaid & other current of $27.50M in Q1 2026.
- How has Neurocrine Biosciences's prepaid & other current changed year-over-year?
- Neurocrine Biosciences's prepaid & other current decreased by 76.9% year-over-year, from $119.30M to $27.50M.
- What is the long-term trend for Neurocrine Biosciences's prepaid & other current?
- Over 5 years (2020 to 2025), Neurocrine Biosciences's prepaid & other current has grown at a -6.9% compound annual growth rate (CAGR), from $30.10M to $21.10M.
- What does prepaid & other current mean?
- Assets representing payments made for future services or miscellaneous short-term holdings.